“Real-life” inhaled corticosteroid withdrawal in COPD: a subgroup analysis of DACCORD

Many patients with chronic obstructive pulmonary disease (COPD) receive inhaled corticosteroids (ICSs) without a clear indication, and thus, the impact of ICS withdrawal on disease control is of great interest. DACCORD is a prospective, noninterventional 2-year study in the primary and secondary car...

Descripción completa

Detalles Bibliográficos
Autores principales: Vogelmeier, Claus, Worth, Heinrich, Buhl, Roland, Criée, Carl-Peter, Lossi, Nadine S, Mailänder, Claudia, Kardos, Peter
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2017
Materias:
Clinical Trial Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5295250/
https://www.ncbi.nlm.nih.gov/pubmed/28203072
http://dx.doi.org/10.2147/COPD.S125616

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5295250/
https://www.ncbi.nlm.nih.gov/pubmed/28203072
http://dx.doi.org/10.2147/COPD.S125616

Ejemplares similares